| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DACT1 mRNA" | 21394737 |
| C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | "2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of DACT1 mRNA" | 19414516 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of DACT1 mRNA" | 19114083 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of DACT1 mRNA | 29067470 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of DACT1 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of DACT1 mRNA | 22100608 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of DACT1 mRNA | 21298039 |
| D000638 | Amiodarone | Amiodarone results in decreased expression of DACT1 mRNA | 24535564 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of DACT1 mRNA | 27829220 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased methylation of DACT1 promoter | 21176356 |
| C006632 | arsenic trioxide | [arsenic trioxide results in decreased methylation of DACT1 promoter] which results in increased expression of DACT1 mRNA | 21176356|2117635 |
| C487081 | belinostat | belinostat results in increased expression of DACT1 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of DACT1 mRNA | 20713471|2156981 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of DACT1 mRNA | 19770486 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of DACT1 mRNA | 20660070 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | 17404688 |
| D004958 | Estradiol | Estradiol results in decreased expression of DACT1 mRNA | 19484750|2521013 |
| C006780 | bisphenol A | bisphenol A affects the expression of DACT1 mRNA | 20170705 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACT1 mRNA | 22079614 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of DACT1 mRNA | 26079696 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of DACT1 mRNA | 22634333 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | 20938992 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of DACT1 mRNA | 24386269 |
| D003471 | Cuprizone | Cuprizone results in increased expression of DACT1 mRNA | 26577399 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of DACT1 mRNA | 27989131 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of DACT1 mRNA | 19770486 |
| D000069439 | Dasatinib | Dasatinib results in increased expression of DACT1 mRNA | 20579391 |
| C014347 | decitabine | [decitabine affects the methylation of DACT1 promoter] which affects the expression of DACT1 mRNA | 18538736|1853873 |
| C014347 | decitabine | decitabine results in decreased expression of DACT1 mRNA | 27915011 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of DACT1 mRNA | 25047013 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DACT1 mRNA | 28628672 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of DACT1 mRNA | 21266533 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of DACT1 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of DACT1 mRNA | 27392435 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of DACT1 mRNA | 21852083 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of DACT1 mRNA] | 21852083 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased expression of DACT1 mRNA | 18242016 |
| D004237 | Diuron | Diuron results in decreased expression of DACT1 mRNA | 25152437 |
| C118739 | entinostat | entinostat results in increased expression of DACT1 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| D000431 | Ethanol | Ethanol results in decreased expression of DACT1 mRNA | 28986285 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of DACT1 mRNA | 28189721 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of DACT1 mRNA | 27219277 |
| C061365 | flusilazole | flusilazole results in increased expression of DACT1 mRNA | 22382673 |
| C061365 | flusilazole | flusilazole affects the expression of DACT1 mRNA | 22634333 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | 20938992 |
| D055768 | Halogenated Diphenyl Ethers | Halogenated Diphenyl Ethers results in increased expression of DACT1 mRNA | 27219277 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DACT1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DACT1 mRNA | 28628672 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of DACT1 mRNA | 27392435 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | 20938992 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in decreased expression of DACT1 mRNA | 20713471 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of DACT1 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of DACT1 mRNA" | 25620056 |
| D009532 | Nickel | Nickel results in decreased expression of DACT1 mRNA | 25583101 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of DACT1 mRNA | 22714537 |
| D010081 | Oxazolone | Oxazolone results in decreased expression of DACT1 mRNA | 18242016 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of DACT1 mRNA | 26272509 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA" | 25510870 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of DACT1 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of DACT1 mRNA | 23811191 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of DACT1 mRNA | 22714537 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in decreased expression of DACT1 mRNA | 23608068 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of DACT1 mRNA | 20660070 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | 17404688 |
| D011374 | Progesterone | Progesterone results in decreased expression of DACT1 mRNA | 17404688 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of DACT1 mRNA | 24780913 |
| D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | 19059307 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of DACT1 mRNA] | 21852083 |
| D012643 | Selenium | Selenium results in decreased expression of DACT1 mRNA | 19244175 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of DACT1 mRNA | 25895662 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of DACT1 mRNA | 22714537 |
| D053260 | Soot | Soot results in decreased expression of DACT1 mRNA | 26551751 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | 19059307 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of DACT1 mRNA | 21570461 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of DACT1 mRNA | 23411599 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of DACT1 mRNA | 28065790 |
| D014051 | Toluene 2,4-Diisocyanate | "Toluene 2,4-Diisocyanate results in decreased expression of DACT1 mRNA" | 18242016 |
| D014212 | Tretinoin | Tretinoin results in increased expression of DACT1 mRNA | 21934132 |
| D014212 | Tretinoin | Tretinoin results in increased expression of DACT1 mRNA | 20488242 |
| D014241 | Trichloroethylene | Trichloroethylene results in decreased expression of DACT1 mRNA | 25549359 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of DACT1 mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of DACT1 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of DACT1 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of DACT1 mRNA | 24535564 |
| D014638 | Vanadates | Vanadates results in increased expression of DACT1 mRNA | 22714537 |
| D002762 | Cholecalciferol | Cholecalciferol results in increased expression of DACT1 mRNA | 17170073 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of DACT1 mRNA | 19244175 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DACT1 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of DACT1 mRNA | 26272509 |